US wholesaler and healthcare services provider AmerisourceBergen has struck a $6.5bn deal with Walgreens Boots Alliance to acquire the majority of the firm’s Alliance Healthcare unit, “one of the largest pharmaceutical wholesalers in Europe,” with a significant UK business. The deal value comprises $6.275bn in cash and 2 million shares of AmerisourceBergen common stock.
Highlighting as part of the deal package Alliance’s Almus range of generics – which it described as “the number one UK generic brand” – as well as the Alvita range of personal care products, AmerisourceBergen also pointed to Alliance’s private-label generics elsewhere
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?